Avrobio
Developer of gene therapies to treat genetic diseases. The company uses a proprietary Plato platform to develop lentiviral gene therapies for lysosomal disorders. The product pipeline includes AVR-RD-02 for Gaucher disease, AVR-RD-04 for cystinosis, and AVR-RD-05 Hunter syndrome. The company was founded in 2016 and headquartered in Cambridge, United States. It has raised $85.5M in series b funding, with backing from…
Funding snapshot
About
Developer of gene therapies to treat genetic diseases. The company uses a proprietary Plato platform to develop lentiviral gene therapies for lysosomal disorders. The product pipeline includes AVR-RD-02 for Gaucher disease, AVR-RD-04 for cystinosis, and AVR-RD-05 Hunter syndrome. The company was founded in 2016 and headquartered in Cambridge, United States. It has raised $85.5M in series b funding, with backing from Citadel, Brace Pharma Capital, Eventide Funds, Atlas Venture, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Gene Therapy, Life Sciences - Rare Diseases space. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.
Business model
Rare Diseases > Drugs > Metabolic Disorders > Lysosomal Diseases,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.